Clinical Trial Update: Concerta (Methylphenidate) -To-Generic Switch Study

View source ↗

Summary

A completed clinical trial evaluating switching from Concerta to a generic methylphenidate formulation for attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Attention Deficit Disorder With Hyperactivity | Status: COMPLETED